Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polaroid Therapeutics has developed proprietary antimicrobial technologies that have demonstrated efficacy in pre-clinical models for both acute and chronic wound management. The technology aims to reduce bioburden—including resistant strains—without promoting antimicrobial resistance. The company’s approach also extends to long-lasting medical device coatings designed to prevent infections associated with implants or catheters. No clinical trial results are available yet; the company remains at the pre-clinical stage but has announced successful completion of key milestones.[2][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Polaroid Therapeutics.